IDPH: Office of Health Promotion

The Illinois Department of Public Health (IDPH) will provide general revenue funds to up to three public or private not-for-profit entity to provide prostate cancer awareness, outreach, and screening statewide, with a focus on high risk populations of Black non- Hispanic males and Hispanic males and in areas with high prostate cancer incidence. This focus is based on Illinois-specific data, objectives from the 2022-2027 Illinois Comprehensive Cancer Control Plan, and current guidelines from the United States Preventive Services Task Force (USPSTF) regarding prostate cancer screening.

N/A

Public Act 102-0017 Section 35

N/A

The Illinois Department of Public Health (IDPH), Illinois Comprehensive Cancer Control Program (ICCCP), will provide general revenue funds to provide prostate cancer awareness, outreach, and screening statewide, with a focus on high risk populations of Black non-Hispanic males and Hispanic males and areas with high prostate cancer incidence.

Yes

N/A

Government Organizations; Public Housing Organizations; For-Profit Organizations;

Partnerships, Tax Exempt, Corporation providing or billing medical and/or health care services, or governmental

N/A

Project Grants

Healthcare

N/A

N/A

Applications must be submitted via the Illinois Department of Public Health's Electronic Grants Administration and Management System (EGrAMS), accessible at www.idphgrants.com. The applicant must complete and upload program specific attachments located in the Miscellaneous section of the application. The grant applications will be reviewed after grant application deadline.

Applications will be reviewed and scored using the following criteria. 1. Scope of Work Section (50 pts) 2. Health Equity (30 pts) 3. Work Plan Section (15 pts) 4. Budget Section (5 pts) This grant is competitive. A merit-based review will be scored by the Department grant committee consisting of two or more reviewers. Scoring is be based on the evaluation criteria listed above.

Anticipated award announcement is October 15, 2021.

Applications must be submitted through the Illinois Department of Public Health Electronic Grants Administration & Management System (EGrAMS). Applications must be received by the close of business (5:00 p.m.) on September 16, 2021. If the applicant encounters technical difficulties with the EGrAMS system, the applicant may contact: IDPH Grants Support E-mail: DPH.GrantReview@illinois.gov.

Anticipated award announcement is October 15, 2021.

This grant is competitive. A merit-based review will be scored by the Department grant committee consisting of two or more reviewers. Scoring is be based on the evaluation criteria listed above. For competitive grants, only the evaluation process is subject to appeal. Evaluation scores or funding determinations/outcomes may not be contested and will not be considered by the Department's Appeals Review Officer. To submit an appeal, the appealing party must: Submit the appeal in writing and in accordance with the grant application document through IDPH's Merit-Based Review Appeal Request Form available in the GATA section of the IDPH website (www.dph.illinois.gov/GATA). Appeals must be received within 14 calendar days after the date that the grant award notice was published. Appeals must include the following information: The name and address of the appealing party; Identification of the grant; A statement of reasons for the appeal; and If applicable, documents or exhibits to support statement of reason. The IDPH Appeals Review Officer (ARO) will consider the grant-related appeals and make a recommendation to the appropriate Deputy Director as expeditiously as possible after receiving all relevant, requested information. The ARO must review the submitted Appeal Request Form for completeness and acknowledge receipt of the appeal within 14 calendar days from the date the appeal was received. The ARO will utilize an Appeal Review Tool to consider the integrity of the competitive grant process and the impact of the recommendation. The appealing party must supply any additional information requested by the agency within the time period set in the request. The ARO shall respond to the appeal within 60 days or supply a written explanation to the appealing party as to why additional time is required. Documentation of the appeal determination shall be sent to the appealing party and must include the following: Standard description of the appeal review process and criteria; Review of the appeal; Appeal determination; and Rationale for the determination In addition to providing the written determination, the grant-making office may do the following: Document improvements to the evaluation process given the findings and re-review all submitted applications. Document improvements to the evaluation process given the findings and implement improvements into the following year's grant evaluation process. Provide written notice to the appealing party as to how the identified actions will be remedied. Appeals resolutions may be deferred pending a judicial or administrative determination when actions concerning the appeal have commenced in a court of administrative body.

N/A

N/A

All grant funds must be used for the sole purposes set forth in the grant proposal and application and must be used in compliance with all applicable laws. Grant funds may not be used as matching funds for any other grant program. Use of grant funds for prohibited purposes may result in loss of grant award and/or place the grantee at risk for recouping of those funds used for the prohibited purpose. Expenditure reports must be submitted monthly. To be reimbursable under the Department/Office of Health Promotion Grant Agreement, expenditures must meet the following general criteria: Be necessary and reasonable for proper and efficient administration of the program and not be a general expense required to carry out the overall responsibilities of the applicant. Be authorized or not prohibited under federal, state or local laws, or regulations. Conform to any limitations or exclusions set forth in the applicable rules, program description, or grant agreement. Be accorded consistent treatment through application of generally accepted accounting principles, appropriate to the circumstances. Not be allocable to or included as a cost of any state or federally-financed program in either the current or a prior period. Be net of all applicable credits. Be specifically identified with the provision of a direct service or program activity. Be an actual expenditure of funds in support of program activities, documented by check number, and/or internal ledger transfer of funds. Not be used for research or clinical care. Unallowable or prohibited uses of grant funds include, but are not limited, to the following: Political or religious purposes. Contributions or donations. Incentives, including but not limited to t-shirts, bags, backpacks, hats, pencils, rulers, coloring books, stress balls, band-aid holders, mugs and cookware. Fundraising or legislative lobbying expenses. Payment of bad or non-program related debts, fines or penalties. Contribution to a contingency fund or provision for unforeseen events. Food, alcoholic beverages, gratuities or entertainment. Membership fees. Interest or financial payments or other fines or penalties. Purchase or improvement of land or purchase, improvement, or construction of a building. Lease of facility space. Any expenditure that may create conflict of interest or the perception of impropriety. Audit expenses. Equipment. Prescription drugs. Conference registration fees, including registration fees to attend or exhibit at events that can be defined as fundraisers. Exhibit fees. Subscriptions. Association dues. Expenses for credentialing (e.g., CHES certification). Airfare. Out-of-state travel.

Grantees are required to submit monthly progress reports on their work plan objectives.

N/A

N/A

N/A

N/A

136000

N/A

N/A

N/A

Springfield

N/A

Additional data is available at https://www.dph.illinois.gov/data-statistics/epidemiology/cancer-registry or https://gis.cdc.gov/Cancer/USCS/DataViz.html

N/A

8/16/2021

FY 2022 : $582,000
FY 2023 : $136,000